ArticleJournal of veterinary internal medicine2026
Analytical validation, reference interval determination, and diagnostic performance of plasma symmetric dimethylarginine in cattle.
Article in Journal of veterinary internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Short-term mortality prediction based on biochemical blood markers in azotemic cattle with renal disease.Journal of veterinary internal medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe efficacy of serum urea and creatinine concentrations in the diagnosis of kidney disease in cattle is limited because of their low sensitivity and specificity. Serum symmetric dimethylarginine (SDMA) concentration is correlated with glomerular filtration rate and has been reported to be useful for the diagnosis of kidney disease in other species. HYPOTHESIS/
objectivesTest the hypothesis that SDMA may be an effective biomarker for diagnosing kidney disease in cattle. The objectives were to assess the analytical performance of SDMA measurement using a benchtop analyzer to establish an SDMA reference interval in cattle, and to evaluate the efficacy of plasma SDMA concentration for the diagnosis of kidney disease in cattle. ANIMALS: A total of 199 healthy animals (53 male and 96 female beef cattle and 50 female dairy cows) and 27 azotemic cows with confirmed kidney disease.
methodsA partial analytical validation of SDMA measurement using bovine plasma was performed including assessments of short- and long-term imprecision, linearity, and stability. The reference interval was established following American Society for Veterinary Clinical Pathology (ASVCP) recommendations. Finally, the diagnostic efficacy of SDMA was assessed by determination of specificity, sensitivity, and the area under the receiver operating characteristic curve.
resultsThe SDMA measurements showed acceptable analytical performance. The reference interval was 60-160 μg/L. No significant differences were found according to sex, breed, or food supply. Using the upper limit of the reference interval (160 μg/L) as the cut-off, sensitivity and specificity were 0.85 and 0.98, respectively. CONCLUSIONS AND CLINICAL IMPORTANCE: An SDMA cut-off of 160 μg/L shows promise for diagnosing kidney disease in cattle, but requires confirmation in future studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.